About us Pricing ContactSubscribe

J

J. Alfred Witjes

Radboud University NijmegenORCID https://orcid.org/0000-0003-0059-3857

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials

European Urology20062,943 citations

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

European Urology20202,116 citationsFirst authorCorresponding

Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer

European Urology20161,500 citationsFirst authorCorresponding

EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2013 Guidelines

European Urology20131,011 citationsFirst authorCorresponding

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

European Urology2009749 citations

DD3PCA3-based Molecular Urine Analysis for the Diagnosis of Prostate Cancer

European Urology2003697 citations

Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies

European Urology2002678 citations

Treatment of Muscle-invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines

European Urology2011675 citations

An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer

European Urology2009650 citations

Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis

European Urology2015650 citations

The Updated EAU Guidelines on Muscle-Invasive and Metastatic Bladder Cancer

European Urology2009640 citations

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours

European Journal of Cancer2005542 citations